321 related articles for article (PubMed ID: 18190497)
1. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion.
Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hoover SL; Alexandrov AV;
J Neuroimaging; 2008 Jan; 18(1):56-61. PubMed ID: 18190497
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Siddiqui M; Alvarez-Sabín J; Uchino K; Calleja S; Alexandrov AV;
Neurology; 2008 Oct; 71(17):1304-12. PubMed ID: 18753474
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke.
Arenillas JF; Ispierto L; Millán M; Escudero D; Pérez de la Ossa N; Dorado L; Guerrero C; Serena J; Castillo J; Dávalos A
Neurology; 2008 Jul; 71(3):190-5. PubMed ID: 18625965
[TBL] [Abstract][Full Text] [Related]
4. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
[TBL] [Abstract][Full Text] [Related]
5. Residual flow at the site of intracranial occlusion on transcranial Doppler predicts response to intravenous thrombolysis: a multi-center study.
Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Shuaib A; Alexandrov AV;
Cerebrovasc Dis; 2009; 27(1):5-12. PubMed ID: 19018132
[TBL] [Abstract][Full Text] [Related]
6. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
[TBL] [Abstract][Full Text] [Related]
7. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
[TBL] [Abstract][Full Text] [Related]
9. Residual flow signals predict complete recanalization in stroke patients treated with TPA.
Labiche LA; Malkoff M; Alexandrov AV
J Neuroimaging; 2003 Jan; 13(1):28-33. PubMed ID: 12593128
[TBL] [Abstract][Full Text] [Related]
10. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke.
Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hill MD; Alexandrov AV;
Stroke; 2007 Mar; 38(3):961-6. PubMed ID: 17255548
[TBL] [Abstract][Full Text] [Related]
11. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion.
Vilas D; Gomis M; Blanco M; Cortés J; Millán M; Pérez de la Ossa N; Dorado L; López-Cancio E; Suñol A; Dávalos A
Chronobiol Int; 2012 Dec; 29(10):1383-9. PubMed ID: 23130962
[TBL] [Abstract][Full Text] [Related]
12. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
13. Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO).
Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Garami Z; Barreto A; Spengos K; Forteza A; Mikulik R; Sharma VK; Brunser A; Martinez P; Montaner J; Kohrmann M; Schellinger PD; Alexandrov AV;
Int J Stroke; 2008 Feb; 3(1):66-72. PubMed ID: 18705918
[TBL] [Abstract][Full Text] [Related]
14. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications.
Zangerle A; Kiechl S; Spiegel M; Furtner M; Knoflach M; Werner P; Mair A; Wille G; Schmidauer C; Gautsch K; Gotwald T; Felber S; Poewe W; Willeit J
Neurology; 2007 Jan; 68(1):39-44. PubMed ID: 17200490
[TBL] [Abstract][Full Text] [Related]
15. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy.
Ribó M; Molina C; Alvarez B; Dinia L; Alvarez-Sabin J; Matas M
J Neuroimaging; 2009 Apr; 19(2):188-90. PubMed ID: 18800999
[TBL] [Abstract][Full Text] [Related]
16. Does intravenous rtPA benefit patients in the absence of CT angiographically visible intracranial occlusion?
Sylaja PN; Dzialowski I; Puetz V; Eliasziw M; Hill MD; Krol A; O'Reilly C; Demchuk AM
Neurol India; 2009; 57(6):739-43. PubMed ID: 20139502
[TBL] [Abstract][Full Text] [Related]
17. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
[TBL] [Abstract][Full Text] [Related]
18. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
[TBL] [Abstract][Full Text] [Related]
19. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
Alexandrov AV; Grotta JC
Neurology; 2002 Sep; 59(6):862-7. PubMed ID: 12297567
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic impact of time-point and degree of arterial recanalization of acute middle cerebral artery occlusions after intravenous tPA administration].
Dorado L; Arenillas JF; Millán M; Pérez De La Ossa N; Guerrero C; Dávalos A
Med Clin (Barc); 2009 May; 132(16):609-15. PubMed ID: 19376550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
